What is the typical dose of Diflucan (fluconazole) for an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Typical Fluconazole (Diflucan) Dosing for Adults

For invasive candidiasis, fluconazole should be administered with a loading dose of 800 mg (12 mg/kg) on day one, followed by 400 mg (6 mg/kg) daily thereafter. 1

Dosing by Indication

Vaginal Candidiasis

  • Single dose of 150 mg orally is the standard treatment for uncomplicated cases 2, 3, 4
  • Clinical cure rates exceed 90% with this single-dose regimen 2
  • For recurrent vulvovaginal candidiasis (≥4 episodes/year), use 150 mg weekly for 6 months as maintenance therapy after initial control 2

Oropharyngeal Candidiasis

  • 200 mg loading dose on day 1, then 100 mg daily for at least 2 weeks 1, 3
  • Alternative dosing: 100-200 mg daily for 7-14 days for moderate-severe disease 2, 5
  • Treatment should continue for at least 2 weeks to decrease relapse likelihood 3

Esophageal Candidiasis

  • 200 mg loading dose on day 1, then 100 mg daily 3
  • Doses up to 400 mg daily may be used based on clinical response 1, 3
  • Minimum treatment duration is 3 weeks and at least 2 weeks after symptom resolution 3

Invasive Candidiasis/Candidemia

  • 800 mg (12 mg/kg) loading dose on day 1, then 400 mg (6 mg/kg) daily 1
  • This loading dose strategy achieves near-steady-state concentrations by day 2 1, 3
  • Continue treatment for 2 weeks after documented clearance from bloodstream 1

Urinary Tract Candidiasis

  • Asymptomatic candiduria: No treatment needed in immunocompetent patients 1, 2
  • Symptomatic cystitis: 200 mg daily for 2 weeks 1, 2
  • Pyelonephritis: 200-400 mg daily for 2 weeks 1

Cryptococcal Meningitis

  • Acute treatment: 400 mg on day 1, then 200-400 mg daily for 10-12 weeks after CSF becomes culture-negative 3
  • Suppressive therapy in AIDS patients: 200 mg daily 3

Prophylaxis in High-Risk Populations

  • Bone marrow transplant recipients: 400 mg daily starting several days before anticipated neutropenia, continuing for 7 days after neutrophil count >1000 cells/mm³ 1, 3
  • ICU patients (high-risk units with >5% invasive candidiasis incidence): 800 mg loading dose, then 400 mg daily 1
  • Neutropenic patients during chemotherapy: 400 mg daily throughout neutropenia period 1, 2
  • High-risk solid organ transplant recipients: 200-400 mg daily for 7-14 days postoperatively 1

Critical Dosing Adjustments

Renal Impairment

  • Creatinine clearance >50 mL/min: No adjustment needed, use 100% of recommended dose 5
  • Creatinine clearance ≤50 mL/min: Reduce to 50% of recommended dose 1, 5
  • Hemodialysis patients: Give 100% of recommended dose after each dialysis session 5

Important Pharmacokinetic Considerations

  • Oral bioavailability is approximately 90%, making oral and IV dosing equivalent 1
  • Absorption is not affected by food, gastric pH, or disease state 1
  • Long half-life of 31-37 hours allows once-daily dosing 6, 7
  • Achieves CSF concentrations 50-89% of serum levels, making it ideal for CNS infections 1, 7
  • Urine concentrations reach 10-20 times serum levels 1

Critical Pitfalls to Avoid

Do not use fluconazole prophylaxis in immunocompetent patients taking antibiotics, even with history of recurrent yeast infections—this promotes resistance without proven benefit 2

Avoid fluconazole for suspected C. glabrata or C. krusei infections as these species have reduced susceptibility; consider echinocandins instead 1

Do not use azole prophylaxis if planning empiric azole therapy—prior azole exposure necessitates switching to an echinocandin for empiric treatment 1

Inadequate treatment duration leads to relapse—continue therapy until clinical parameters and laboratory tests indicate active infection has subsided 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fluconazole Prophylaxis and Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of vaginal candidiasis with a single oral dose of fluconazole. Multicentre Study Group.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988

Guideline

Fluconazole Dosing in Geriatric Patients with Impaired Renal Function

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Fluconazole: a new triazole antifungal agent.

DICP : the annals of pharmacotherapy, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.